Skip to main content

Table 1 Types of cancers and the associated chemotherapy regimens [2]

From: Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program

Type of Cancer (incidence ranking) Associated chemotherapy regimen
Males
 Basal cell carcinoma Topical Fluorouracil
 Prostate Cancer Docetaxel and Prednisone
 Squamous cell carcinoma 5-Flourouracil, Cisplatin or Carboplatin
 Non-small cell lung cancer Cisplatin, and Vinorelbine, or Docetaxel, or Gemcitabine, or Etoposide
 Small cell lung cancer Cisplatin or Carboplatin, Etoposide
 Oesophageal Cancer Cisplatin, 5-Fluorouracil, Docetaxel, Oxaliplatin, Capecitabine
Females
 Breast Doxorubicin/Cycloplosphamide, Paclitaxel, Trastuzumab, Carboplatin, 5-Fluorouracil, Epirubicin
 Cervix Cisplatin, Paclitaxel, Carboplatin, Gemcitabine
 Basal cell carcinoma Topical Fluorouracil
 Squamous cell carcinoma 5-Flourouracil, Cisplatin or Carboplatin
Colon Oxaliplatin, Capecitabine, 5-Fluorouracil